University Of Connecticut Health Center

University of Connecticut Health Center, doing business as Grant Administration, operates as a state-controlled academic medical center and comprehensive research institution that functions as a prime recipient of federal research grants and as a subcontractor on research and service delivery programs across the National Institutes of Health, Department of Defense, Department of the Navy, and other federal agencies. The entity is a child organization within the Connecticut state government structure under the Secretary of State.

The institution's federal footprint centers on biomedical research and medical education delivery. As a prime recipient, UCHC receives substantial grant funding from the National Institutes of Health across multiple institutes—the National Institute on Aging, National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, National Cancer Institute, and the National Heart, Lung, and Blood Institute dominate the portfolio by award count. Recent representative research grants include a $1.28 million NIAID award for deciphering Borrelia burgdorferi regulatory networks in Lyme disease (CFDA 93.855), a $825 thousand NIAID grant examining glycosylated RNA control of immune homeostasis (CFDA 93.855), a $680 thousand NINDS award developing next-generation RNA inhibitors for ischemic stroke therapy (CFDA 93.853), and a $658 thousand NIAMS grant developing engineered periarticular injection therapy for knee osteoarthritis (CFDA 93.846). The institution also holds several Navy training contracts for tuition and fees supporting medical education programs, including delivery orders valued between $14 thousand and $128 thousand for Navy personnel training at its Farmington, Connecticut campus.

Customer concentration skews heavily toward federal research agencies, particularly the NIH, which represents roughly 30% of award count across its component institutes. The Navy Bureau of Medicine and Surgery, through purchase orders and basic ordering agreements, constitutes the second-largest customer by volume (69 awards) and combined potential value ($1.6 million). The Department of Health and Human Services Centers for Disease Control and Prevention ranks highest by potential-value concentration ($2.1 million across 17 awards), reflecting large-scale cooperative agreements. The source data reflects a 1,228-award portfolio spanning 1968 to the present, with recent annual activity averaging 55–88 awards across FY2022–FY2025, with 37 awards recorded year-to-date in 2026.

UCHC operates primarily as a prime recipient (86% of awards) rather than a subcontractor (14%). On the research side, the institution subcontracts to and collaborates with peer research institutions including Jackson Laboratory (spatial transcriptomics analysis, immunology studies, microbiome research), Yale University, Duke University, University of Pittsburgh, and The Jackson Laboratory on multi-institutional NIH and defense-funded projects. Representative subcontractor relationships include a Jackson Laboratory arrangement for conducting computational analysis and developing PL-Seq libraries on an NIH award, and a Duke University collaboration for vaccine development and antibody studies against syphilis pathogens. The institution also engages Connecticut Children's Medical Center and University of Nebraska Medical Center as sub-awardees on Defense Health Agency grants for composite tissue wound healing research. Service Contract Inventory (SCI) reporting shows minimal prime service-contract activity; across FY2022–FY2024, UCHC reported 6 SCI records in a subcontractor capacity with approximately 0.7 to 0.4 FTEs, indicating limited engagement in the federal service-contract supply chain relative to its grant research footprint.

The research portfolio spans basic biomedical science (stem cell biology, molecular mechanisms of disease), translational research (drug delivery systems, engineered therapies), clinical trials (maternal resuscitation, substance use disorder interventions, dementia care), and health services research (workforce development, health equity). No set-aside designations, SBA certifications, or minority-ownership profiles apply; UCHC is a state government entity under Connecticut's direct control. The institution's federal engagement is concentrated in grants (CFDA 93.xxx series predominates) rather than competitive service contracts or task orders, reflecting its role as an academic research and medical education center rather than a federal services vendor.